© 1993 Oxford University Press
RESEARCH-ARTICLE |
Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR
1Department of Internal Medicine, Biological Chemistry, University of Michigan Ann Arbor, MI 48109 2Department of Anatomy and Cell Biology, University of Michigan Ann Arbor, MI 48109 3Department of Human Genetics, University of Michigan Ann Arbor, MI 48109 4Department of Medicine, Duke University and VA Medical Center Durham, NC 27710 5Department of Physiology and Biophysics, University of Alabama at Birmingham Birmingham, AL 35294, USA
*To whom correspondence should be addressed
Received February 5, 1993; Revised June 14, 1993; Accepted June 14, 1993
Cystic fibrosis (CF) is caused by mutations in the gene encoding a chloride channel called the CF transmembrane conductance regulator (CFTR). A single mutation in this gene, deletion of three nucleotides that leads to the absence of phenylalanine 508 (i.e.,
F508), is found on 70% of all CF chromosomes. To explore the molecular mechanism(s) responsible for defective chloride transport in patients with CF, we have studied the processing, localization, and function of wild type (W.T.),
F508 and G551D CFTR (a G
D missense mutation at position 551) in retrovirus transduced L cells. Cell transduced with W.T. CFTR expressed a 170 kd CFTR protein that was endoglycosidase H (Endo H) resistant, localized to the plasma membrane, and generated a cAMP-mediated anion conductance (GCl) when stimulated with standard concentrations of forskolin (5 µM), cpt cAMP (400 µM) and IBMX (100 µM). The G551D CFTR was indistinguishable from W.T. CFTR with respect to post-translational processing and localization, but it did not produce a cAMP-activated GCI in response to the standard stimulation cocktail. However, raising the IBMX concentration to 4 mM produced Gc, in G551D expressing cells. Cells transduced with
F508 CFTR expressed an Endo H sensitive CFTR protein (
140 kd) that was found in a cytosolic, perinuclear location. These cells did not respond to the standard cocktail, but
20% of cells increased GCI when the cocktail contained 4 mM IBMX. Incubation of cells at 26°C for 48 hours prior to analysis elicited responses in
F508 expressing cells at low IBMX concentrations, but had no effect on the responses of cells expressing W.T. or G551D CFTR. The response of
F508 to 26°C was associated with plasma membrane localization of CFTR protein. These results suggest that there are two mechanisms whereby CFTR mutations lead to loss of cAMP-responsive GCI. First, shown by G551D CFTR, the protein can be processed and targeted to the plasma membrane correctly, but lack full responsiveness to stimulation by cAMP. Second, as examplified by
F508 CFTR, a partially functional protein which is not targeted to its correct cellular location can also lead to loss of the cAMP, responsive GCI.
+present address: Institute for Human Gene Therapy, University of Pennsylvania Medical Center, The Wistar Institute, Room 204, 36th and Spruce Streets, Philadelphia, PA 19104, USA
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. R. Silvis, C. A. Bertrand, N. Ameen, F. Golin-Bisello, M. B. Butterworth, R. A. Frizzell, and N. A. Bradbury Rab11b Regulates the Apical Recycling of the Cystic Fibrosis Transmembrane Conductance Regulator in Polarized Intestinal Epithelial Cells Mol. Biol. Cell, April 15, 2009; 20(8): 2337 - 2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Trzcinska-Daneluti, D. Ly, L. Huynh, C. Jiang, C. Fladd, and D. Rotin High-content Functional Screen to Identify Proteins that Correct F508del-CFTR Function Mol. Cell. Proteomics, April 1, 2009; 8(4): 780 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sun, Z. Mi, S. B. Condliffe, C. A. Bertrand, X. Gong, X. Lu, R. Zhang, J. D. Latoche, J. M. Pilewski, P. D. Robbins, et al. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia FASEB J, September 1, 2008; 22(9): 3255 - 3263. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Wendeler, O. Nufer, and H.-P. Hauri Improved maturation of CFTR by an ER export signal FASEB J, August 1, 2007; 21(10): 2352 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cormet-Boyaka, A. Di, S. Y. Chang, A. P. Naren, A. Tousson, D. J. Nelson, and K. L. Kirk CFTR chloride channels are regulated by a SNAP-23/syntaxin 1A complex PNAS, September 17, 2002; 99(19): 12477 - 12482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Dormer, R. Derand, C. M. McNeilly, Y. Mettey, L. Bulteau-Pignoux, T. Metaye, J.-M. Vierfond, M. A. Gray, L. J. V. Galietta, M. R. Morris, et al. Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells J. Cell Sci., March 13, 2002; 114(22): 4073 - 4081. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Cobb, F. Ruiz, C. M. King, J. Fortenberry, H. Greer, T. Kovacs, E. J. Sorscher, and J. P. Clancy A2 adenosine receptors regulate CFTR through PKA and PLA2 Am J Physiol Lung Cell Mol Physiol, January 1, 2002; 282(1): L12 - L25. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Singh, B. D. Schultz, J. A. Katzenellenbogen, E. M. Price, R. J. Bridges, and N. A. Bradbury Estrogen Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator-Mediated Chloride Secretion J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 195 - 204. [Abstract] [Full Text] |
||||
![]() |
B. D. SCHULTZ, A. K. SINGH, D. C. DEVOR, and R. J. BRIDGES Pharmacology of CFTR Chloride Channel Activity Physiol Rev, January 1, 1999; 79(1): 109 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. BRADBURY Intracellular CFTR: Localization and Function Physiol Rev, January 1, 1999; 79(1): 175 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Bebok, C. J. Venglarik, Z. Panczel, T. Jilling, K. L. Kirk, and E. J. Sorscher Activation of Delta F508 CFTR in an epithelial monolayer Am J Physiol Cell Physiol, August 1, 1998; 275(2): C599 - C607. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mohammad-Panah, S. Demolombe, D. Riochet, V. Leblais, G. Loussouarn, H. Pollard, I. Baro, and D. Escande Hyperexpression of recombinant CFTR in heterologous cells alters its physiological properties Am J Physiol Cell Physiol, February 1, 1998; 274(2): C310 - C318. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang, W. G. Hill, J. M. Pilewski, and O. A. Weisz Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent Am J Physiol Lung Cell Mol Physiol, November 1, 1997; 273(5): L913 - L920. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Cotten, L. S. Ostedgaard, M. R. Carson, and M. J. Welsh Effect of Cystic Fibrosis-associated Mutations in the Fourth Intracellular Loop of Cystic Fibrosis Transmembrane Conductance Regulator J. Biol. Chem., August 30, 1996; 271(35): 21279 - 21284. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jovov, I. I. Ismailov, B. K. Berdiev, C. M. Fuller, E. J. Sorscher, J. R. Dedman, M. A. Kaetzel, and D. J. Benos Interaction between Cystic Fibrosis Transmembrane Conductance Regulator and Outwardly Rectified Chloride Channels J. Biol. Chem., December 8, 1995; 270(49): 29194 - 29200. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Pasyk and J. K. Foskett Mutant ([IMAGE]F508) Cystic Fibrosis Transmembrane Conductance Regulator Cl[IMAGE] Channel Is Functional When Retained in Endoplasmic Reticulum of Mammalian Cells J. Biol. Chem., May 26, 1995; 270(21): 12347 - 12350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Van Oene, G. L. Lukacs, and J. M. Rommens Cystic Fibrosis Mutations Lead to Carboxyl-terminal Fragments That Highlight an Early Biogenesis Step of the Cystic Fibrosis Transmembrane Conductance Regulator J. Biol. Chem., June 23, 2000; 275(26): 19577 - 19584. [Abstract] [Full Text] [PDF] |
||||









